Indivior Pharmaceuticals, Inc. Common Stock (NASDAQ: INDV) last traded at $36.87, down 2.41% on the session. The quote above updates while this page is open; the figures below are drawn from Indivior Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Indivior Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker INDV. Its market capitalisation is $4.35 billion.
Valuation measures for Indivior Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.35B |
|---|---|
| Enterprise value | $5.57B |
| P/E ratio | 13.22 |
| Price / sales | 3.27 |
| Beta | 0.42 |
Trailing-twelve-month figures tagged in Indivior Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.33B |
|---|---|
| Net income (TTM) | $356.00M |
| EPS (TTM) | $2.79 |
| Gross margin | 82.19% |
| Operating margin | 31.63% |
| Cash | $222.00M |
Range and volume for INDV over the past 52 weeks.
| 52-week high | $42.81 |
|---|---|
| 52-week low | $22.22 |
| Volume | 1.92M |
| Average volume | 2.02M |
| Previous close | $37.78 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.